Primecap Management Co. CA Grows Holdings in LivaNova PLC (NASDAQ:LIVN)

Primecap Management Co. CA increased its stake in LivaNova PLC (NASDAQ:LIVN) by 0.7% in the second quarter, Holdings Channel reports. The institutional investor owned 5,981,200 shares of the company’s stock after acquiring an additional 44,049 shares during the quarter. Primecap Management Co. CA owned 0.11% of LivaNova worth $327,889,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Fifth Third Bancorp grew its holdings in LivaNova by 97.1% during the 2nd quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock worth $37,000 after acquiring an additional 332 shares in the last quarter. Hexagon Capital Partners LLC grew its stake in LivaNova by 117.8% in the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after purchasing an additional 370 shares in the last quarter. Lazard Asset Management LLC bought a new stake in LivaNova in the first quarter valued at about $84,000. Acadian Asset Management LLC acquired a new stake in LivaNova during the first quarter valued at approximately $94,000. Finally, TradeLink Capital LLC bought a new position in LivaNova during the 2nd quarter worth approximately $208,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on LIVN. Needham & Company LLC boosted their price target on LivaNova from $72.00 to $75.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. Stifel Nicolaus increased their target price on shares of LivaNova from $70.00 to $72.00 and gave the stock a “buy” rating in a report on Thursday, July 25th. Finally, Robert W. Baird reaffirmed a “neutral” rating and issued a $55.00 price target on shares of LivaNova in a report on Wednesday, August 28th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $68.60.

LivaNova Price Performance

Shares of NASDAQ LIVN opened at $48.79 on Tuesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 3.45 and a quick ratio of 2.94. The firm has a market capitalization of $2.65 billion, a PE ratio of -81.32 and a beta of 1.00. LivaNova PLC has a 1-year low of $42.75 and a 1-year high of $64.47. The business’s fifty day moving average price is $48.85 and its two-hundred day moving average price is $53.47.

LivaNova (NASDAQ:LIVN) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.15. LivaNova had a negative net margin of 1.37% and a positive return on equity of 13.77%. The firm had revenue of $318.60 million for the quarter, compared to the consensus estimate of $305.05 million. On average, research analysts expect that LivaNova PLC will post 2.58 EPS for the current year.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.